Cardinal Health Inc
CAH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$285.00 | Ywqxxh | Lbssdvhm |
Cardinal Health Earnings: Sales Growth Starts to Slow but Margin Comes Through
Narrow-moat Cardinal Health reported third-quarter earnings that came in largely as we expected. Total sales of $54.9 billion was up 8.8% year over year thanks to stable utilization prescription trend and strong execution. All three segments posting a sequential margin improvement was also a nice surprise. After adjusting our 2024 and 2025 assumptions and baking in time value of money, we raise our fair value estimate to $92 per share from $88.